Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
Phase 3
1(50.0%)
2Total
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05919277Unknown

A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires

Role: lead

NCT05213364Unknown

Dengue Vaccine Hesitancy and Acceptance in Endemic Regions of Argentina: Impact of Communication Strategies

Role: lead

NCT03734939Unknown

Health and Cardiovascular Risk Factors in Slums.

Role: lead

NCT00793754Phase 4Completed

Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People

Role: lead

NCT00597220Phase 3Unknown

Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation

Role: lead

All 5 trials loaded